Edwards Lifesciences Europe — Goodwill (Note 11) increased by 12.7% to $62.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.7%, from $55.20M to $62.20M.
An increase typically reflects recent acquisitions in the region, while a decrease may indicate impairment charges or divestitures.
This metric represents the total carrying value of goodwill allocated to the European business segment. It reflects the...
Peers in the medical device industry report similar goodwill balances based on their regional M&A activity and historical purchase price allocations.
ew_segment_europe_goodwill_note_11| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $63.00M | $59.40M | $61.40M | $55.20M | $62.20M |
| QoQ Change | — | -5.7% | +3.4% | -10.1% | +12.7% |
| YoY Change | — | -5.7% | +3.4% | -10.1% | +12.7% |